KUALA LUMPUR, Feb 22 (Bernama) -- Korea's innovative venture company, Jowin has set this year as its first year of entering the global cancer care market and will establish a global telemedicine platform that provides high-quality non-face-to-face care services to patients with stage 4 and terminal cancer.
According to Jowin in a statement, it plans to launch a telemedicine platform that can be accessed via its smartphone application in the first half of 2023, and will gradually expand the platform into the global market after its first launch in Korea and Southeast Asian countries.
"I have been able to give hope to many cancer patients by treating those in Korea who have been abandoned by modern medicine, through Jowin’s affiliated cancer hospital for numerous years.
“We wish to adopt the non-face-to-face telemedicine method to help overseas cancer patients connect with named doctors in the cancer treatment field in Korea,” said Jowin chairman, Soo-hyun Kim.
Jowin’s telemedicine platform will be available worldwide to cancer patients and caregivers. When the basic personal information and condition of a cancer patient is registered on the app, a “cansultant”, a counselor specialising in cancer patients at Jowin, reviews the patient's medical record and provides them a consultation service for the patient’s current status and other factors.
Through its telemedicine platform, Jowin will provide patients with a total solution that includes “UNBIJE”, a natural anti-cancer drug made from a natural mineral, “HiB&D”, a nutritional supplement exclusively for cancer patients, a protein supplement to support immunity and nutritional balance, and a “body temperature-raising mineral water” that has been filed to the United States Food and Drug Administration.
With the launch of its global telemedicine platform, Jowin plans to recruit partners in various countries. The partners will recruit and train local cansultants and cancer patients who are difficult to treat with modern medicine to provide them with telemedicine services or medical tours to excellent cancer treatment hospitals affiliated with Jowin in Korea.
-- BERNAMA
No comments:
Post a Comment